Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Real-world adherence, persistence, and health care resource utilization among people with HIV receiving long-acting cabotegravir plus rilpivirine compared with oral antiretroviral therapy in the United States: The ABOVE StudyCindy Garris, Maral DerSarkissian, Rose Chang, et al.
Open Forum Infectious Diseases|April 30, 2025
Clinical Outcomes and Perspectives of People With Human Immunodeficiency Virus Type 1 Twelve Months After Initiation of Long-acting Cabotegravir and Rilpivirine in an Observational Real-world US Study (BEYOND)Dima Dandachi, Cindy Garris, David Richardson, et al.
Therapeutic Advances in Infectious Disease|December 18, 2023
Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirineParul Patel, Paula Teichner, Emilie Elliot, et al.
Open Forum Infectious Diseases|June 17, 2024
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection AdministrationPaula Teichner, Nadine Chamay, Emilie Elliot, et al.
Pageof 1